Lucentis and Remeron drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lucentis (ranibizumab) and Remeron (mirtazapine). Common drug interactions include abdominal pain among females and abscess among males.

The phase IV clinical study analyzes what interactions people have when they take Lucentis and Remeron. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Lucentis?

Lucentis has active ingredients of ranibizumab. It is often used in macular degeneration. eHealthMe is studying from 25,647 Lucentis users. Check the latest studies of Lucentis.

What is Remeron?

Remeron has active ingredients of mirtazapine. It is often used in depression. eHealthMe is studying from 26,474 Remeron users. Check the latest studies of Remeron.

On Jul, 11, 2026

17 people who take Lucentis and Remeron together, and have interactions are studied.

What are the common drug interactions of Lucentis and Remeron, by gender? *:

female:

Abdominal pain
Acute prerenal failure (prerenal acute renal failure (arf) occurs when a sudden reduction in blood flow to the kidney)
Ascites (accumulation of fluid in the abdominal cavity)
Blood creatinine increased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cardiac murmur (an heart sound in valve abnormality)
Cellulitis (infection under the skin)
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Dyspepsia (indigestion)

male:

Abscess (pus)
Activities of daily living impaired
Bone cyst
Bone disorder
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Calculus urinary (stone in urinary system)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)
Cardiomyopathy (weakening of the heart muscle)

What are the common drug interactions of Lucentis and Remeron, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Azotaemia (excess of urea or other nitrogenous compounds in the blood)
Back pain
Balance disorder
Blood glucose increased
Bone cyst
Bone disorder
Bone swelling
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Calculus urinary (stone in urinary system)

40-49:

n/a

50-59:

n/a

60+:

Hypoaesthesia (reduced sense of touch or sensation)
Abscess (pus)
Balance disorder
Bone cyst
Bone disorder
Bundle branch block left (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the left ventricle)
Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
Calculus urinary (stone in urinary system)
Cardiac failure congestive
Cardiomegaly (increased size of heart than normal)

What are the existing conditions these people have? *

Toothaches (tooth pain): 8 people, 47.06%
Muscle Spasms (muscle contraction): 8 people, 47.06%
Choroidal Neovascularisation (creation of new blood vessels in vascular layer of eye): 3 people, 17.65%
Bone Neoplasm Malignant (cancer of bone): 3 people, 17.65%
Osteoporosis (bones weak and more likely to break): 2 people, 11.76%
Age-Related Macular Degeneration: 2 people, 11.76%
Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 1 person, 5.88%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 5.88%
Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 1 person, 5.88%
Breast Cancer Female: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lucentis and Remeron?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously